Learner Objectives After participating in this activity, learners should be able to: Episode Specific: Summarize the history and background of opioid prescribing legislation over the years. List the stakeholders involved in addressing the opioid use public health crisis in Washington state. Understand the effects of HB1427 and SB5380 on opioid prescribing in Washington state and have strategies to comply with them. Get engaged in Olympia and testify on rules and regulation of important medical issues. Podcast Series: Increase safe opioid prescribing practices in line with HB1427. Have strategies to tailor opioid management services to their specialty and organization using evidence-based practices on appropriate prescribing and data-driven practices. Help reduce the development of tolerance to opioids. Address long-term pain management, and appropriately treat opioid addiction.Taking into account how well the learner objectives were met, how would you rate the podcast episode?1=Poor23=Good45=ExcellentPlease rate the host Nathan Schlicher, MD, JD, MBA, FACEP.1=Poor23=Good45=ExcellentContent ExpertiseCommunication SkillsPlease rate the guest speaker Jeb Shepard, Director of Policy, WSMA.1=Poor23=Good45=ExcellentContent ExpertiseCommunication SkillsWhat barriers are you experiencing in your practice, with respect to opioid prescribing?As a result of listening/watching, what strategies will you adapt to use in your practice? An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests. Did you perceive any bias toward a “commercial interest” in any presentation? Yes No If Yes, please explain.Do you want CME credit?(Required) Yes No
